
Blipra T 4000mg/500mg Injection
Marketer
Blesslife healthcare
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Blipra T 4000mg/500mg Injection
Combiflox 4000mg/500mg injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, the dosage and frequency are determined by a physician based on individual health status. Strict adherence to prescribed usage is essential. Commonly reported side effects involve gastrointestinal upset (nausea, vomiting, diarrhea) and skin reactions (rash). Injection site inflammation (pain, swelling, redness) may also occur. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor, who may adjust the medication accordingly. Under medical supervision, this medication is generally considered safe for pregnant and breastfeeding individuals.
Uses of Blipra T 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Blipra T 4000mg/500mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Blipra T 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Blipra T 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Blipra T 4000mg/500mg Injection works:
Blipra T Injection (4000mg/500mg) unites Piperacillin, a crucial antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactum's role is to counter bacterial resistance, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Blipra T 4000mg/500mg Injection shows no adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Blipra T (4000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no harmful consequences to fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Blipra T (4000mg/500mg) presents minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no discernible threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Blipra T 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Blipra T 4000mg/500mg Injection to individuals with impaired renal function requires careful consideration. Dosage modification for Blipra T 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Blipra T 4000mg/500mg Injection in patients with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Blipra T 4000mg/500mg Injection :
Omitting a scheduled dose of Blipra T 4000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Blipra T 4000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Agents against infection |
